Joachim Taminau

Journal Article
A1
open access

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Nele Vandenbussche (UGent) , Renske Imschoot (UGent) , Béatrice Lintermans (UGent) , Lode Denolf (UGent) , Joachim Taminau (UGent) , Charlotte Fieuws, Geert Berx (UGent) , Kris Gevaert (UGent) and Kathleen Claes (UGent)

(2025) MOLECULAR ONCOLOGY. 19. p.3360-3375

Add to list

Journal Article
A1
open access

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

Sven Jonckheere, Joachim Taminau (UGent) , Jamie Adams, Jef Haerinck (UGent) , Jordy De Coninck (UGent) , Jeroen Verstappe (UGent) , Kato De Clercq (UGent) , Evelien Peeters (UGent) , Alexander Gheldof (UGent) , Eva De Smedt (UGent) , et al.

(2025) CELL DEATH AND DIFFERENTIATION. 32(11). p.2078-2092

Add to list

Journal Article
A1
open access

ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states

Jeroen Verstappe (UGent) , Nicolas Skrypek (UGent) , Jordy De Coninck (UGent) , Bieke Soen (UGent) , Joachim Taminau (UGent) , Marianthi Tatari, Kenneth Bruneel, Nele Loret (UGent) , Kato De Clercq (UGent) , Caroline Van den Broecke (UGent) , et al.

(2024) ISCIENCE. 27(11).

Add to list

Journal Article
A1
open access

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia

Lisa Demoen (UGent) , Filip Matthijssens (UGent) , Lindy Reunes (UGent) , Bruno Palhais (UGent) , Béatrice Lintermans (UGent) , Sara T'Sas (UGent) , Igor Fijalkowski (UGent) , Joachim Taminau (UGent) , Muluembet Z. Akele, Siska Van Belle, et al.

(2024) SCIENCE ADVANCES. 10(44).

Add to list

Distinct transcriptional programs in ascitic and solid cancer cells induce different responses to chemotherapy in high-grade serous ovarian cancer

Nele Loret (UGent) , Niels Vandamme (UGent) , Jordy De Coninck (UGent) , Joachim Taminau (UGent) , Kato De Clercq (UGent) , Gillian Blancke (UGent) , Sven Jonckheere, Steven Goossens (UGent) , Kelly Lemeire (UGent) , Sofie De Prijck (UGent) , et al.

(2022) MOLECULAR CANCER RESEARCH. 20(10). p.1532-1547

Add to list

Zeb2 drives invasive and microbiota-dependent colon carcinoma

Karolina Slowicka (UGent) , Ioanna Petta (UGent) , Gillian Blancke (UGent) , Esther Hoste (UGent) , Emilie Dumas (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , Enrico Radaelli, Jody J. Haigh, Sven Jonckheere, et al.

(2020) NATURE CANCER. 1(6). p.620-634

Add to list

Miscellaneous

Publisher correction : Zeb2 drives invasive and microbiota-dependent colon carcinoma

Karolina Slowicka (UGent) , Ioanna Petta (UGent) , Gillian Blancke (UGent) , Esther Hoste (UGent) , Emilie Dumas (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , Enrico Radaelli, Jody J. Haigh, Sven Jonckheere, et al.

(2020) NATURE CANCER. 1(7). p.750-750

Add to list

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Niels Vandamme (UGent) , Geertrui Denecker (UGent) , Kenneth Bruneel, Gillian Blancke (UGent) , Ozden Akay, Joachim Taminau (UGent) , Jordy De Coninck (UGent) , Eva De Smedt (UGent) , Nicolas Skrypek (UGent) , Wouter Van Loocke (UGent) , et al.

(2020) CANCER RESEARCH. 80(14). p.2983-2995

Add to list

Journal Article
A1
open access

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma

Elien De Thaye, Koen Van de Vijver (UGent) , Joni Van der Meulen (UGent) , Joachim Taminau (UGent) , Glenn Wagemans, Hannelore Denys (UGent) , Jo Van Dorpe (UGent) , Geert Berx (UGent) , Wim Ceelen (UGent) , Jan Van Bocxlaer (UGent) , et al.

(2020) SCIENTIFIC REPORTS. 10(1).

Add to list

Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection

Tania Love Aaes (UGent) , Hanne Verschuere (UGent) , Agnieszka Kaczmarek (UGent) , Liesbeth Heyndrickx (UGent) , Bartosz Wiernicki, Iris Delrue (UGent) , Bram De Craene (UGent) , Joachim Taminau (UGent) , Tinneke Delvaeye (UGent) , Mathieu Bertrand (UGent) , et al.

(2020) JOURNAL OF IMMUNOLOGY. 204(4). p.775-787

Academic Bibliography

Joachim Taminau

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia

Distinct transcriptional programs in ascitic and solid cancer cells induce different responses to chemotherapy in high-grade serous ovarian cancer

Zeb2 drives invasive and microbiota-dependent colon carcinoma

Publisher correction : Zeb2 drives invasive and microbiota-dependent colon carcinoma

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma

Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection

Contents

Support

Contact